All data are based on the daily closing price as of December 20, 2024
c

Chong Kun Dang Pharmaceutical

185750.KO
62.63 USD
-0.49
-0.78%

Overview

Last close
62.63 usd
Market cap
787.12M usd
52 week high
102.77 usd
52 week low
55.43 usd
Target price
106.95 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
0.684
Price/Book Value
1.2764
Enterprise Value
706.52M usd
EV/Revenue
0.6091
EV/EBITDA
4.5344

Key financials

Revenue TTM
1.15B usd
Gross Profit TTM
375.64M usd
EBITDA TTM
189.89M usd
Earnings per Share
N/A usd
Dividend
0.76 usd
Total assets
1,468.05B usd
Net debt
N/A usd

About

Chong Kun Dang Pharmaceutical Corp. engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally. It provides prescription drugs for anticancer, anti-hypertension, anti-hyperlipidemia, anti-diabetic, and immunosuppressant products; over-the-counter drugs for therapeutic benefits, supplements, and other preventive products; health supplements with preventive benefits, including prebiotics and vitamins with Omega-3; and consumer health products, such as red-ginseng healthy drink, hand sanitizer, and hair color medication, as well as insecticides. The company also exports its products. Chong Kun Dang Pharmaceutical Corp. was founded in 1941 and is headquartered in Seoul, South Korea.
  • Symbol
    185750.KO
  • Exchange
    KO
  • Isin
    KR7185750007
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Young-Joo Kim
  • Headquarter
    Seoul
  • Web site
    https://www.ckdpharm.com

Related news

Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top